Back to News
Market Impact: 0.2
Ginkgo Bioworks (DNA) Surges 11.1%: Is This an Indication of Further Gains?
Source: zacks.com
Analyst EstimatesHealthcare & BiotechInvestor Sentiment & Positioning
Ginkgo Bioworks shares were a notable recent mover on above-average trading volume, but unfavorable earnings-estimate revision trends may limit further near-term upside. The article provides no specific price, volume, or estimate-revision figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
DNA-0.35
More News
- Exclusive-US weighs allowing most pharma licensing deals with China, sources say
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- Warren Buffett stepping down as chairman of Berkshire Hathaway: 'Father Time always wins'
- Three words from Kevin Warsh have Wall Street wondering how far the Fed will go with rate hikes
- Bond Income Is Easing Some of the Pain in Treasury Selloff
- European stocks snap two-week slide as Fed resolve